Cambridge Investment Research Advisors, Inc. 23and Me Holding Co. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$0.71 - $0.97 $72,895 - $99,589	-102,670 Reduced 56.74%	78,273 $72,000
Q3 2023 Oct 24, 2023	SELL	$0.96 - $2.01 $36,246 - $75,891	-37,757 Reduced 17.26%	180,943 $177,000
Q2 2023 Jul 13, 2023	BUY	$1.59 - $2.29 $7,676 - $11,056	4,828 Added 2.26%	218,700 $383,000
Q1 2023 May 11, 2023	SELL	$2.05 - $2.87 $282 - $396	-138 Reduced 0.06%	213,872 $488,000
Q4 2022 Feb 08, 2023	BUY	$2.06 - $3.47 $14,858 - $25,029	7,213 Added 3.49%	214,010 $462,000
Q3 2022 Oct 17, 2022	SELL	$2.6 - $5.12 $10,199 - $20,085	-3,923 Reduced 1.86%	206,797 $591,000
Q2 2022 Jul 13, 2022	SELL	$2.19 - $3.98 $5,161 - $9,380	-2,357 Reduced 1.11%	210,720 $522,000
Q1 2022 May 12, 2022	BUY	$3.28 - $7.12 $53,896 - $116,995	16,432 Added 8.36%	213,077 $816,000
Q4 2021 Feb 03, 2022	BUY	$6.55 - $13.25 $58,085 - $117,501	8,868 Added 4.72%	196,645 $1.31 Million
Q3 2021 Nov 02, 2021	BUY	$7.29 - $11.0 $1.23 Million - $1.86 Million	169,163 Added 908.79%	187,777 $1.7 Million
Q2 2021 Aug 10, 2021	BUY	$9.87 - $13.32 $183,720 - $247,938	18,614 New	18,614 $217,000

Others Institutions Holding ME

# of Institutions

116

Shares Held

82.6M

Call Options Held

404K

Put Options Held

292K

New View Capital Partners I, LLC Burlingame, CA

19.5M
Shares

$74.3 Million
18.63% of portfolio
Vanguard Group Inc Valley Forge, PA

15.6M
Shares

$59.5 Million
0.0% of portfolio
Euclidean Capital LLC New York, NY

10.2M
Shares

$39.1 Million
0.4% of portfolio
Sapphire Ventures, L.L.C. Austin, TX

5.29M
Shares

$20.2 Million
1.93% of portfolio
Black Rock Inc. New York, NY

4.66M
Shares

$17.8 Million
0.0% of portfolio

View Full List

About 23andMe Holding Co.

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $992M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

More about ME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account